Petro Terblanche

Professor Petro Terblanche has played a key part in the design and implementation of South Africa’s biotechnology strategy since 2002. She holds the position of Chief Executive Officer of Afrigen Biologics (Pty)Ltd (www.afrigen.co.za) based in Cape Town, South Africa. She has qualifications which include: a Master of Science and a Doctor of Science in Medical Oncology from the University of Pretoria, post-doctoral she was a visiting scientist at Harvard University School of Public Health and thereafter, completed a Management of Technology program at Massachusetts Institute of Technology. Prof Terblanche is the author of more than 200 scientific publications and conference papers on public health. She was recently acknowledged as one of the legends of science by the Academy of Sciences South Africa.